Dimer Health

You have TCM Revenue on the table. We help capture it.

Enter your discharge volume to model annual ROI across billing, readmission reduction, and total cost of care — grounded in peer-reviewed Medicare data.

📄 NORC/ASPE 2023 📄 AJMC 2024

Your organization

Total annual discharges

all payers

Medicare Discharges

5,000 non-Medicare discharges — see commercial upside below
Current TCM capture rate 16%
0%100%

Industry avg: 16.2% (NORC 2023)

Target TCM Capture Rate with Dimer 65%
0%100%
Dimer platform fee (annual) $180K
$50K$500K

Estimated for illustrative purposes only. Actual platform fees are determined following a formal proposal based on payer mix, discharge complexity, and usage analysis. Contact Dimer Health for a tailored quote.

HRRP penalty exposure $0
$0$5M

Optional: known or estimated CMS readmission penalty

Data sources & benchmarks used TCM reimbursement: $259 avg (CPT 99495/99496 blend) · Rehospitalization reduction: −0.6 pp (NORC 2023) · Avg readmission cost: $15,500 · TCOC reduction: $236/episode (days 31–60, excl. readmissions, NORC 2023) · HDAH gain: +0.32 days/episode · Readmission reduction: 28.7/1,000 (AJMC 2024)

Medicare ROI projection

Total estimated annual return

$0

— return on Dimer investment

Top Line Revenue Growth for TCM Visit
(incremental claims captured)

$0

Resulting Readmission Cost Avoidance after TCM Visit
(−28.7 readmits/1,000 with TCM)

$0

Total cost of care reduction
(days 31–60 post-discharge, excl. readmissions)

$0

HRRP penalty avoidance
(readmission penalty offset)

$0

0

New TCM claims annually

0

Readmissions avoided

0

Additional healthy days at home

Return multiple on investment

Revenue & savings breakdown

🔓

Commercial & Medicare Advantage upside

Based on your 5,000 non-Medicare discharges

Estimate — coverage varies by contract
How to read this section. Unlike Medicare, there is no national claims database quantifying commercial TCM uptake. CPT 99495/99496 are recognized by most major commercial payers and all Medicare Advantage plans (Part B parity required). Estimates apply the same NORC/AJMC benchmarks adjusted for lower expected capture rates. Actual reimbursement depends on individual payer contracts.

Medicare Advantage

MA share of Medicare discharges 54%
0%100%

MA covers ~54% of Medicare enrollees nationally (KFF 2024)

MA TCM capture target 60%
0%100%

MA new TCM billing revenue

$0

MA readmission avoidance

$0

Commercial / other payers

Non-Medicare discharges eligible for TCM 40%
0%100%

Adjust for your payer mix — not all commercial plans reimburse TCM

Commercial TCM capture target 35%
0%100%

Commercial new TCM billing revenue

$0

Commercial readmission avoidance

$0

Estimated additional upside (commercial + MA)

Not included in Medicare ROI above — shown separately

$0

Medicare projections grounded in NORC/ASPE (2023) and AJMC (2024) peer-reviewed claims data. Commercial estimates are illustrative — no equivalent national claims study exists for private payer TCM uptake. Reimbursement rates, coverage, and capture rates vary by contract. TCM CPT 99495/99496 recognized by Medicare, Medicare Advantage (Part B parity required), and most major commercial payers. This tool is for illustrative purposes only.

* CMS TCM requirements — met by Dimer Connect and AiMe. CMS requires that Transitional Care Management services include: (1) an interactive contact with the patient and/or caregiver, as appropriate, within 2 business days of discharge, using telephone, Advanced Communication Technology, or face-to-face interaction (42 C.F.R. § 410.78; CPT 99495/99496 code descriptor); and (2) a face-to-face visit within 7 calendar days of discharge for CPT 99496 (medical decision-making of high complexity) or within 14 calendar days for CPT 99495 (medical decision-making of moderate complexity). Dimer Connect fulfills the required post-discharge interactive contact through its bi-directional patient communication platform, and AiMe, Dimer’s AI care navigation technology, actively identifies and routes eligible patients to schedule the required face-to-face visit within the applicable 7- or 14-day window. Together, these capabilities operationalize the non-face-to-face care management services required throughout the 30-day TCM period.

Ready to see a custom projection for your health system?